ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 33 filers reported holding ACORDA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $816,000 | -8.3% | 996,000 | -2.3% | 0.06% | +7.8% |
Q2 2016 | $890,000 | -65.2% | 1,019,000 | -64.6% | 0.05% | -64.8% |
Q1 2016 | $2,554,000 | -62.3% | 2,880,000 | -51.1% | 0.14% | -51.3% |
Q4 2015 | $6,768,000 | +1.4% | 5,885,000 | -20.4% | 0.30% | -15.3% |
Q3 2015 | $6,676,000 | -10.9% | 7,397,000 | 0.0% | 0.35% | +13.9% |
Q2 2015 | $7,489,000 | -1.0% | 7,397,000 | +0.1% | 0.31% | +3.3% |
Q1 2015 | $7,568,000 | -21.0% | 7,392,000 | -11.2% | 0.30% | -25.6% |
Q4 2014 | $9,579,000 | +5.7% | 8,325,000 | -4.7% | 0.40% | +6.1% |
Q3 2014 | $9,065,000 | – | 8,737,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |